Global Peptide-based Drug Market Research Report 2025(Status and Outlook)

March 2025 | 224 pages | ID: G5E6AFE749ACEN
Bosson Research

Abstracts

Report Overview

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

This report provides a deep insight into the global Peptide-based Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide-based Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide-based Drug market in any manner.

Global Peptide-based Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

Teva

Novo Nordisk

Takeda

Eli Lilly

AstraZeneca

Novartis

AbbVie

Ipsen

Ferring

Merck

The Medicines

J & J

Market Segmentation (by Type)

Injection

Oral

Other

Market Segmentation (by Application)

Cancer

Metabolic Disorders

Central Nervous System

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Peptide-based Drug Market
• Overview of the regional outlook of the Peptide-based Drug Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peptide-based Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Peptide-based Drug
1.2 Key Market Segments
  1.2.1 Peptide-based Drug Segment by Type
  1.2.2 Peptide-based Drug Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL PEPTIDE-BASED DRUG MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Peptide-based Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Peptide-based Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL PEPTIDE-BASED DRUG MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Peptide-based Drug Product Life Cycle
3.3 Global Peptide-based Drug Sales by Manufacturers (2020-2025)
3.4 Global Peptide-based Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Peptide-based Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Peptide-based Drug Manufacturing Sites, Area Served, Product Type
3.8 Peptide-based Drug Market Competitive Situation and Trends
  3.8.1 Peptide-based Drug Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Peptide-based Drug Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PEPTIDE-BASED DRUG INDUSTRY CHAIN ANALYSIS

4.1 Peptide-based Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PEPTIDE-BASED DRUG MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Peptide-based Drug Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Peptide-based Drug Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL PEPTIDE-BASED DRUG MARKET BY REGION

6.1 Global Peptide-based Drug Market Size by Region
  6.1.1 Global Peptide-based Drug Market Size by Region
  6.1.2 Global Peptide-based Drug Market Size Market Share by Region
6.2 Global Peptide-based Drug Sales by Region
  6.2.1 Global Peptide-based Drug Sales by Region
  6.2.2 Global Peptide-based Drug Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Peptide-based Drug Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Peptide-based Drug Market Size by Type
7.3 North America Peptide-based Drug Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Peptide-based Drug Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Peptide-based Drug Market Size by Type
8.3 Europe Peptide-based Drug Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Peptide-based Drug Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Peptide-based Drug Market Size by Type
9.3 Asia-Pacific Peptide-based Drug Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Peptide-based Drug Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Peptide-based Drug Market Size by Type
10.3 South America Peptide-based Drug Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Peptide-based Drug Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Peptide-based Drug Market Size by Type
11.3 Middle East and Africa Peptide-based Drug Market Size by Application

12 PEPTIDE-BASED DRUG MARKET PRODUCTION BY REGION

12.1 Global Production of Peptide-based Drug by Region(2020-2025)
12.2 Global Peptide-based Drug Revenue Market Share by Region (2020-2025)
12.3 Global Peptide-based Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Peptide-based Drug Production
  12.4.1 North America Peptide-based Drug Production Growth Rate (2020-2025)
  12.4.2 North America Peptide-based Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Peptide-based Drug Production
  12.5.1 Europe Peptide-based Drug Production Growth Rate (2020-2025)
  12.5.2 Europe Peptide-based Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Peptide-based Drug Production (2020-2025)
  12.6.1 Japan Peptide-based Drug Production Growth Rate (2020-2025)
  12.6.2 Japan Peptide-based Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Peptide-based Drug Production (2020-2025)
  12.7.1 China Peptide-based Drug Production Growth Rate (2020-2025)
  12.7.2 China Peptide-based Drug Production, Revenue, Price and Gross Margin (2020-2025)

13 PEPTIDE-BASED DRUG MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Peptide-based Drug Sales Market Share by Type (2020-2033)
13.3 Global Peptide-based Drug Market Size Market Share by Type (2020-2033)
13.4 Global Peptide-based Drug Price by Type (2020-2033)

14 PEPTIDE-BASED DRUG MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Peptide-based Drug Market Sales by Application (2020-2033)
14.3 Global Peptide-based Drug Market Size (M USD) by Application (2020-2033)
14.4 Global Peptide-based Drug Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Sanofi
  15.1.1 Sanofi Basic Information
  15.1.2 Sanofi Peptide-based Drug Product Overview
  15.1.3 Sanofi Peptide-based Drug Product Market Performance
  15.1.4 Sanofi Business Overview
  15.1.5 Sanofi SWOT Analysis
  15.1.6 Sanofi Recent Developments
15.2 Teva
  15.2.1 Teva Basic Information
  15.2.2 Teva Peptide-based Drug Product Overview
  15.2.3 Teva Peptide-based Drug Product Market Performance
  15.2.4 Teva Business Overview
  15.2.5 Teva SWOT Analysis
  15.2.6 Teva Recent Developments
15.3 Novo Nordisk
  15.3.1 Novo Nordisk Basic Information
  15.3.2 Novo Nordisk Peptide-based Drug Product Overview
  15.3.3 Novo Nordisk Peptide-based Drug Product Market Performance
  15.3.4 Novo Nordisk Business Overview
  15.3.5 Novo Nordisk SWOT Analysis
  15.3.6 Novo Nordisk Recent Developments
15.4 Takeda
  15.4.1 Takeda Basic Information
  15.4.2 Takeda Peptide-based Drug Product Overview
  15.4.3 Takeda Peptide-based Drug Product Market Performance
  15.4.4 Takeda Business Overview
  15.4.5 Takeda Recent Developments
15.5 Eli Lilly
  15.5.1 Eli Lilly Basic Information
  15.5.2 Eli Lilly Peptide-based Drug Product Overview
  15.5.3 Eli Lilly Peptide-based Drug Product Market Performance
  15.5.4 Eli Lilly Business Overview
  15.5.5 Eli Lilly Recent Developments
15.6 AstraZeneca
  15.6.1 AstraZeneca Basic Information
  15.6.2 AstraZeneca Peptide-based Drug Product Overview
  15.6.3 AstraZeneca Peptide-based Drug Product Market Performance
  15.6.4 AstraZeneca Business Overview
  15.6.5 AstraZeneca Recent Developments
15.7 Novartis
  15.7.1 Novartis Basic Information
  15.7.2 Novartis Peptide-based Drug Product Overview
  15.7.3 Novartis Peptide-based Drug Product Market Performance
  15.7.4 Novartis Business Overview
  15.7.5 Novartis Recent Developments
15.8 AbbVie
  15.8.1 AbbVie Basic Information
  15.8.2 AbbVie Peptide-based Drug Product Overview
  15.8.3 AbbVie Peptide-based Drug Product Market Performance
  15.8.4 AbbVie Business Overview
  15.8.5 AbbVie Recent Developments
15.9 Ipsen
  15.9.1 Ipsen Basic Information
  15.9.2 Ipsen Peptide-based Drug Product Overview
  15.9.3 Ipsen Peptide-based Drug Product Market Performance
  15.9.4 Ipsen Business Overview
  15.9.5 Ipsen Recent Developments
15.10 Ferring
  15.10.1 Ferring Basic Information
  15.10.2 Ferring Peptide-based Drug Product Overview
  15.10.3 Ferring Peptide-based Drug Product Market Performance
  15.10.4 Ferring Business Overview
  15.10.5 Ferring Recent Developments
15.11 Merck
  15.11.1 Merck Basic Information
  15.11.2 Merck Peptide-based Drug Product Overview
  15.11.3 Merck Peptide-based Drug Product Market Performance
  15.11.4 Merck Business Overview
  15.11.5 Merck Recent Developments
15.12 The Medicines
  15.12.1 The Medicines Basic Information
  15.12.2 The Medicines Peptide-based Drug Product Overview
  15.12.3 The Medicines Peptide-based Drug Product Market Performance
  15.12.4 The Medicines Business Overview
  15.12.5 The Medicines Recent Developments
15.13 J and J
  15.13.1 J and J Basic Information
  15.13.2 J and J Peptide-based Drug Product Overview
  15.13.3 J and J Peptide-based Drug Product Market Performance
  15.13.4 J and J Business Overview
  15.13.5 J and J Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Peptide-based Drug Market Size by Type (M USD)
Table 4. Global Peptide-based Drug Market Size by Application (M USD)
Table 5. Peptide-based Drug Market Size Comparison by Region (M USD)
Table 6. Global Peptide-based Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Peptide-based Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Peptide-based Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Peptide-based Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2024)
Table 11. Global Market Peptide-based Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Peptide-based Drug Manufacturing Sites and Area Served
Table 13. Manufacturers Peptide-based Drug Product Type
Table 14. Global Peptide-based Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide-based Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Peptide-based Drug Market Size Comparison by Region (M USD)
Table 26. Global Peptide-based Drug Market Size by Region (2020-2033) & (M USD)
Table 27. Global Peptide-based Drug Market Size Market Share by Region (2020-2033)
Table 28. Global Peptide-based Drug Sales by Region (2020-2033) & (K MT)
Table 29. Global Peptide-based Drug Sales Market Share by Region (2020-2033)
Table 30. North America Peptide-based Drug Market Size by Country (2020-2033) & (M USD)
Table 31. North America Peptide-based Drug Sales by Country (2020-2033) & (K MT)
Table 32. North America Peptide-based Drug Sales by Type (K MT)
Table 33. North America Peptide-based Drug Market Size by Type (M USD)
Table 34. North America Peptide-based Drug Sales (K MT) by Type (2020-2033)
Table 35. North America Peptide-based Drug Market Size (M USD) by Type (2020-2033)
Table 36. North America Peptide-based Drug Sales by Application (K MT)
Table 37. North America Peptide-based Drug Market Size by Application (M USD)
Table 38. North America Peptide-based Drug Sales (K MT) by Application (2020-2033)
Table 39. North America Peptide-based Drug Market Size (M USD) by Application (2020-2033)
Table 40. Europe Peptide-based Drug Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Peptide-based Drug Sales by Country (2020-2033) & (K MT)
Table 42. Europe Peptide-based Drug Sales by Type (K MT)
Table 43. Europe Peptide-based Drug Market Size by Type (M USD)
Table 44. Europe Peptide-based Drug Sales (K MT) by Type (2020-2033)
Table 45. Europe Peptide-based Drug Market Size (M USD) by Type (2020-2033)
Table 46. Europe Peptide-based Drug Sales by Application (K MT)
Table 47. Europe Peptide-based Drug Market Size by Application (M USD)
Table 48. Europe Peptide-based Drug Sales (K MT) by Application (2020-2033)
Table 49. Europe Peptide-based Drug Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Peptide-based Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Peptide-based Drug Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Peptide-based Drug Sales by Type (K MT)
Table 53. Asia-Pacific Peptide-based Drug Market Size by Type (M USD)
Table 54. Asia-Pacific Peptide-based Drug Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Peptide-based Drug Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Peptide-based Drug Sales by Application (K MT)
Table 57. Asia-Pacific Peptide-based Drug Market Size by Application (M USD)
Table 58. Asia-Pacific Peptide-based Drug Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Peptide-based Drug Market Size (M USD) by Application (2020-2025)
Table 60. South America Peptide-based Drug Market Size by Country (2020-2033) & (M USD)
Table 61. South America Peptide-based Drug Sales by Country (2020-2033) & (K MT)
Table 62. South America Peptide-based Drug Sales by Type (K MT)
Table 63. South America Peptide-based Drug Market Size by Type (M USD)
Table 64. South America Peptide-based Drug Sales (K MT) by Type (2020-2033)
Table 65. South America Peptide-based Drug Market Size (M USD) by Type (2020-2033)
Table 66. South America Peptide-based Drug Sales by Application (K MT)
Table 67. South America Peptide-based Drug Market Size by Application (M USD)
Table 68. South America Peptide-based Drug Sales (K MT) by Application (2020-2033)
Table 69. South America Peptide-based Drug Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Peptide-based Drug Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Peptide-based Drug Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Peptide-based Drug Sales by Type (K MT)
Table 73. Middle East and Africa Peptide-based Drug Market Size by Type (M USD)
Table 74. Middle East and Africa Peptide-based Drug Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Peptide-based Drug Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Peptide-based Drug Sales by Application (K MT)
Table 77. Middle East and Africa Peptide-based Drug Market Size by Application (M USD)
Table 78. Middle East and Africa Peptide-based Drug Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Peptide-based Drug Market Size (M USD) by Application (2020-2033)
Table 80. Global Peptide-based Drug Production (K MT) by Region(2020-2025)
Table 81. Global Peptide-based Drug Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Peptide-based Drug Revenue Market Share by Region (2020-2025)
Table 83. Global Peptide-based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Peptide-based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Peptide-based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Peptide-based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Peptide-based Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Peptide-based Drug Sales by Type (K MT)
Table 89. Global Peptide-based Drug Market Size by Type (M USD)
Table 90. Global Peptide-based Drug Sales (K MT) by Type (2020-2033)
Table 91. Global Peptide-based Drug Sales Market Share by Type (2020-2033)
Table 92. Global Peptide-based Drug Market Size (M USD) by Type (2020-2033)
Table 93. Global Peptide-based Drug Market Size Share by Type (2020-2033)
Table 94. Global Peptide-based Drug Sales (K MT) by Application
Table 95. Global Peptide-based Drug Market Size by Application(M USD)
Table 96. Global Peptide-based Drug Sales by Application (2020-2033) & (K MT)
Table 97. Global Peptide-based Drug Sales Market Share by Application (2020-2033)
Table 98. Global Peptide-based Drug Market Size by Application (2020-2033) & (M USD)
Table 99. Global Peptide-based Drug Market Share by Application (2020-2033)
Table 100. Global Peptide-based Drug Sales Growth Rate by Application (2020-2033)
Table 101. Sanofi Basic Information
Table 102. Sanofi Peptide-based Drug Product Overview
Table 103. Sanofi Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Sanofi Business Overview
Table 105. Sanofi SWOT Analysis
Table 106. Sanofi Recent Developments
Table 107. Teva Basic Information
Table 108. Teva Peptide-based Drug Product Overview
Table 109. Teva Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Teva Business Overview
Table 111. Teva SWOT Analysis
Table 112. Teva Recent Developments
Table 113. Novo Nordisk Basic Information
Table 114. Novo Nordisk Peptide-based Drug Product Overview
Table 115. Novo Nordisk Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Novo Nordisk Business Overview
Table 117. Novo Nordisk SWOT Analysis
Table 118. Novo Nordisk Recent Developments
Table 119. Takeda Basic Information
Table 120. Takeda Peptide-based Drug Product Overview
Table 121. Takeda Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Takeda Business Overview
Table 123. Takeda Recent Developments
Table 124. Eli Lilly Basic Information
Table 125. Eli Lilly Peptide-based Drug Product Overview
Table 126. Eli Lilly Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Eli Lilly Business Overview
Table 128. Eli Lilly Recent Developments
Table 129. AstraZeneca Basic Information
Table 130. AstraZeneca Peptide-based Drug Product Overview
Table 131. AstraZeneca Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. AstraZeneca Business Overview
Table 133. AstraZeneca Recent Developments
Table 134. Novartis Basic Information
Table 135. Novartis Peptide-based Drug Product Overview
Table 136. Novartis Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Novartis Business Overview
Table 138. Novartis Recent Developments
Table 139. AbbVie Basic Information
Table 140. AbbVie Peptide-based Drug Product Overview
Table 141. AbbVie Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. AbbVie Business Overview
Table 143. AbbVie Recent Developments
Table 144. Ipsen Basic Information
Table 145. Ipsen Peptide-based Drug Product Overview
Table 146. Ipsen Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Ipsen Business Overview
Table 148. Ipsen Recent Developments
Table 149. Ferring Basic Information
Table 150. Ferring Peptide-based Drug Product Overview
Table 151. Ferring Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Ferring Business Overview
Table 153. Ferring Recent Developments
Table 154. Merck Basic Information
Table 155. Merck Peptide-based Drug Product Overview
Table 156. Merck Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Merck Business Overview
Table 158. Merck Recent Developments
Table 159. The Medicines Basic Information
Table 160. The Medicines Peptide-based Drug Product Overview
Table 161. The Medicines Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. The Medicines Business Overview
Table 163. The Medicines Recent Developments
Table 164. J and J Basic Information
Table 165. J and J Peptide-based Drug Product Overview
Table 166. J and J Peptide-based Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. J and J Business Overview
Table 168. J and J Recent Developments
List of Figures
Figure 1. Product Picture of Peptide-based Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide-based Drug Market Size (M USD), 2024-2033
Figure 5. Global Peptide-based Drug Market Size (M USD) (2020-2033)
Figure 6. Global Peptide-based Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide-based Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Peptide-based Drug Product Life Cycle
Figure 13. Peptide-based Drug Sales Share by Manufacturers in 2024
Figure 14. Global Peptide-based Drug Revenue Share by Manufacturers in 2024
Figure 15. Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Peptide-based Drug Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Peptide-based Drug Revenue in 2024
Figure 18. Industry Chain Map of Peptide-based Drug
Figure 19. Global Peptide-based Drug Market PEST Analysis
Figure 20. Global Peptide-based Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Peptide-based Drug Market Size by Region
Figure 27. Global Peptide-based Drug Market Size Market Share by Region (2020-2033)
Figure 28. Global Peptide-based Drug Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Peptide-based Drug Market Size (M USD) by Country
Figure 33. USA Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Peptide-based Drug Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Peptide-based Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Peptide-based Drug Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Peptide-based Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Peptide-based Drug Market Size (M USD)by Type
Figure 40. North America Peptide-based Drug Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Peptide-based Drug Market Size (M USD) by Country
Figure 45. Germany Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Peptide-based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Peptide-based Drug Market Size (M USD) by Type
Figure 56. Europe Peptide-based Drug Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Peptide-based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Peptide-based Drug Market Size (M USD) by Country
Figure 61. China Peptide-based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Peptide-based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Peptide-based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Peptide-based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Peptide-based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Peptide-based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Peptide-based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Peptide-based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Peptide-based Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Peptide-based Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Peptide-based Drug Market Size (M USD) by Type
Figure 72. Asia-Pacific Peptide-based Drug Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Peptide-based Drug Market Size (M USD) by Country
Figure 77. Brazil Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Peptide-based Drug Market Size (M USD) by Type
Figure 84. South America Peptide-based Drug Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Peptide-based Drug Market Size (M USD) by Country
Figure 89. Saudi Arabia Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Peptide-based Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Peptide-based Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Peptide-based Drug Market Size (M USD) by Type
Figure 100. Middle East and Africa Peptide-based Drug Market Size (M USD) by Application
Figure 101. Global Peptide-based Drug Production Market Share by Region (2020-2025)
Figure 102. North America Peptide-based Drug Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Peptide-based Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Peptide-based Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. China Peptide-based Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Peptide-based Drug Market Size by Type (M USD)
Figure 108. Sales Market Share of Peptide-based Drug by Type (2020-2033)
Figure 109. Sales Market Share of Peptide-based Drug by Type in 2024
Figure 110. Market Size Share of Peptide-based Drug by Type (2020-2033)
Figure 111. Market Size Share of Peptide-based Drug by Type in 2024
Figure 112. Global Peptide-based Drug Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Peptide-based Drug Market Size by Application(M USD)
Figure 115. Global Peptide-based Drug Market Share by Application
Figure 116. Global Peptide-based Drug Sales Market Share by Application (2020-2033)
Figure 117. Global Peptide-based Drug Sales Market Share by Application in 2024
Figure 118. Global Peptide-based Drug Market Share by Application (2020-2033)
Figure 119. Global Peptide-based Drug Market Share by Application in 2024
Figure 120. Global Peptide-based Drug Sales Growth Rate by Application (2020-2033)